AH
Asad Haider Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
33.3%
Neutral
50%
Negative
16.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $37 |
4%
upside
| 1 | – |
–
| 2 Dec ‘25 yesterday |
|
|
|
Neutral
Maintained
| $57 |
12%
upside
| 1 | – |
–
| 2 Dec ‘25 yesterday |
|
|
|
Buy
Maintained
| $212 |
3%
upside
| 1 | +17% |
0
%
| 9 Oct ‘25 1 month ago |
|
|
|
Sell
Initiated
| $17 |
19%
downside
| 1 | -9.6% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Buy
Initiated
| $42 |
6%
upside
| 1 | +12% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Neutral
Initiated
| $38 |
20%
downside
| 1 | – |
–
| 12 Sep ‘25 2 months ago |
|